lung cancer

Multiple sclerosis, lung cancer, and 50 marathons: Aaron Hawkins about to reach amazing milestone

“He has been a blessing and role model for so many,” his doctor Jonathan Nesbitt says.

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

AI used to identify patients at risk for lung cancer

Clinical trial tests ATR inhibitor in difficult-to-treat cancers

Facebook campaign quickly nets clinical trial participants

The cost and effectiveness of social media as a participant recruitment tool for clinical research is still being evaluated. To better understand its utility, researchers at Vanderbilt University Medical Center used Facebook to mount a short, monthlong pilot campaign in and around Houston attempting to recruit participants for an ongoing smoking cessation study being conducted in that city.

Study shows benefit of scheduling lung screens with mammograms

Women who are longtime smokers could potentially save their lives by undergoing lung screens on the same day they schedule mammograms, according to a study by Vanderbilt researchers published in the Journal of Medical Screening.

1 2 3 4 8